Related Experiment Videos
Soluble gentamicin ophthalmic inserts as a drug delivery system
Archives of Ophthalmology (Chicago, Ill. : 1960)
|May 1, 1978
Summary
Soluble collagen inserts delivered the highest concentration of gentamicin to rabbit eyes compared to other methods. This novel ophthalmic insert offers a convenient and atraumatic way to treat corneal infections.
Area of Science:
- Ophthalmology
- Pharmacology
- Biomaterials Science
Background:
- Gentamicin is a crucial antibiotic for treating bacterial eye infections.
- Current delivery methods like eye drops, ointments, and subconjunctival injections have limitations in achieving optimal drug concentrations.
- Developing effective drug delivery systems is essential for combating ocular infections.
Purpose of the Study:
- To compare the efficacy of a novel soluble collagen gentamicin ophthalmic insert against traditional administration routes.
- To quantify and compare gentamicin levels in ocular tissues and tear film across different delivery methods.
- To evaluate the potential of collagen inserts for enhanced ocular drug delivery.
Main Methods:
- Radiolabeled 14C-gentamicin was incorporated into soluble collagen inserts.
- Ophthalmic inserts, eye drops, ointment, and subconjunctival injections were administered to rabbits.
- Tear film, corneal, and scleral tissue samples were collected and analyzed for 14C-gentamicin concentration.
Main Results:
- The soluble collagen insert (wafer) route achieved the highest concentration of 14C-gentamicin in both tear film and ocular tissues.
- Subconjunctival injection resulted in unexpectedly low tear film concentrations of the drug.
- The insert demonstrated superior drug delivery compared to drops and ointment.
Conclusions:
- Soluble collagen inserts represent a promising new method for delivering high doses of gentamicin to infected corneal tissue.
- This delivery system offers a convenient and atraumatic approach for treating ocular infections.
- The insert's ability to achieve high tissue drug concentrations warrants further investigation for clinical application.